Angiogenesis, the formation of new blood vessels from pre-existing vasculature, is fundamental for tumour growth, progression and metastasis [1] 
Introduction
Angiogenesis, the formation of new blood vessels from pre-existing vasculature, is fundamental for tumour growth, progression and metastasis [1] [2] . [3] . In zebrafish, isthmin expression could be up-regulated by overexpression of Wnt8 or down-regulated by Wnt/␤-catenin inhibitor, indicating its involvement in Wnt signalling regulated processes during embryonic development [4] . (Fig. 1A ) [3] . TSR was initially identified in the natural angiogenesis inhibitor TSP-1 and plays a critical role for the anti-angiogenic activity of TSP-1 [5, 6] . TSR has since been found in many secreted proteins or the extracellular portions of transmembrane proteins [7] . [8] . Besides the common cysteine residues that are shared by all AMOPs among different proteins, AMOP in ISM also has a 'KGD' motif, which is found in many antagonists of platelet aggregation and involved in integrin-dependent cell adhesion and tumour metastasis [9] [10] [11] . Therefore, the interaction between AMOP containing proteins and integrin may be involved in regulating angiogenesis. We therefore investigated the role of ISM in angiogenesis. 
. Inhibition of angiogenesis is a promising therapeutic approach for cancer. Angiogenesis inhibitors are being investigated for applications in cancer therapies. Under normal physiological conditions, angiogenesis is believed to be regulated by a local balance of endogenous stimulators and inhibitors. Endogenous protein angiogenesis inhibitors include a few gene products such as thrombospondin-1 (TSP-1) and pigment epithelium-derived factor as well as a large number of protein proteolytic fragments such as angiostatin, endostatin and tumstatin

Although angiogenic stimulators act on endothelial cells (ECs) to stimulate angiogenesis, angiogenic inhibitors tend to be pleiotropic in function and their expression is not necessarily related to angiogenesis regulation. Up to now, very few genes that encode proteins that specifically inhibit angiogenesis have been discovered and their physiological roles are divergent. Isthmin (ISM) is a secreted protein first identified in Xenopus but its function is not yet known. During neuronal stage, ISM is highly expressed in the isthmus organizer, the signalling centre located at the midbrain-hindbrain boundary (MHB). Additional expression was detected in the paraxial mesoderm and neural folds in tail bud stage as well as in notochord in neuronal stage
Sequence analysis indicated that ISM contains a centrally localized thrombospondin type 1 repeat (TSR) and a C-terminal domain
Isthmin is a novel secreted angiogenesis inhibitor that inhibits tumour growth in mice
The functions of TSRs appear to be related to cell migration, communication and tissue remodelling. The other domain in ISM, AMOP, is a predicted protein domain containing eight invariant cysteine residues and is also found only in secreted proteins or the extracellular domains of transmembrane proteins. AMOP domain is speculated to be involved in cell adhesion due to its presence in cell adhesion molecules
Cell migration assay
Cell chemotaxis migration assay was performed with 8 m Falcon cell culture inserts as previously described [12] . 
Generation of anti-ISM antibody
Recombinant mouse ISM purified from E. coli using the same method described above was used for generation of anti-ISM antibody. Anti-serum were raised in rabbits and purified by Biogenes GmbH (Berlin, Germany) using standard procedures. 
Immunoprecipitation and immunoblot
Zebrafish studies
Zebrafish were maintained at standard conditions [16] . Embryos were staged according to the standard morphologic criteria [17] [18] .
Zebrafish isthmin full length sequence (NM_001012376) were cloned into pGEM-T easy vector by RT-PCR using primers zismf (TGGCGGCGGAGCTGCTGCTGCTTT) and zismr (GTTTATAG-TAGTCCTCATCCTGAGGG). The pGEMT-easy/zism plasmid was linearized using NcoI, and SP6 polymerase was used for DIG-labelled antisense RNA synthesis. DIG-labelled RNA probe was synthesized using the in vitro DIG labelling kit (Roche)
. Zebrafish in situ hybridization procedures were performed as previously described [19] .
Statistical analysis
Statistical analysis was performed with paired Student's t-test as indicated.
A P-value of less than 0.05 was considered significant in all cases (*P Ͻ 0.05; **P Ͻ 0.01). (Fig. 1B) . The recombinant proteins were purified by Ni-NTA affinity chromatography followed by further reverse-phase HPLC purification (Fig. 1C) Fig. 2A 
Results
Cloning and expression of recombinant mouse isthmin and its truncated fragments in E. coli
ISM inhibits in vitro capillary network formation through its C-terminal AMOP domain
ECs can rapidly align and form tubular structures within 6-8 hrs when cultured on Matrigel [20]. We premixed ECs with different concentrations of ISM, ISM-C, ISM-N or ISM-TSR and plated them onto Matrigel and monitored the extent of capillary network formation. All capillary network formations were documented at 6 hrs after ECs were plated onto Matrigel. As shown in
ISM inhibited VEGF-, bFGF-or serum-induced EC proliferation without affecting EC migration
To analyse the mechanisms of ISM function, we examined the effects of ISM and its truncated fragments on the various aspects of in vitro angiogenesis. VEGF is the most important endothelialspecific angiogenic growth factor, stimulating multiple aspects of angiogenesis [23] . ISM or its fragments has no effect on VEGFstimulated chemotactic (directional) EC migration (Fig. 4A more details in Fig. S1 ). ISM also did not influence EC chemokinesis (non-directional migration) in the presence or absence of VEGF (Fig. S2A and B) .
However, ISM significantly inhibited VEGF-induced EC proliferation in a dose-dependent manner (Fig. 4B) S5A and B) and has no effect on serum-stimulated tumour cell proliferation (Fig. S5C and D) .
ISM induced EC apoptosis in the presence of VEGF, bFGF or serum
ISM dose-dependently induced EC apoptosis in the presence of VEGF (Fig. 4C and more details in Fig. S6A ). The extent of apoptosis induced by 1 M ISM in the presence of VEGF is similar to apoptosis induced by serum withdrawal (control in Fig. 4C ). This apoptosis induction appears to be caspase dependent because the Pan-caspase inhibitor Z-VAD-fmk effectively abolished this function (Fig. 4C) . Furthermore, ISM dose-dependently induced the activation of caspase 3, a key downstream caspase in the extrinsic as well as intrinsic apoptosis pathways (Fig. S6B) (Fig. 5A and data not shown) . Similarly, ISM also did not influence EC spreading on these matrix molecules (Fig. S9) . On the other hand, ECs can attach and spread onto ISM-coated surface in a similar fashion compared to gelatincoated surface (Fig. 5B) . Furthermore, ISM-C but not ISM-N could support this attachment and spreading (Fig. 5B) . These attachment results are in line with results of Fig. 2 
ISM binds to ECs through ␣v␤ 5 integrin
Integrins are the major cell surface receptors mediating cell adhesion to matrix molecules and play important roles in angiogenesis [24] . Fig. 6 , only integrin ␣v␤5 was co-immunoprecipitated by anti-His antibody (Fig. 6A and B 
We therefore investigated the interaction of ISM with integrins expressed in ECs. We isolated the plasma membrane extract of cultured ECs and incubated with recombinant ISM in vitro. ECs are known to express ␣v␤3, ␣v␤5 and a series of ␤1 integrins. Coimmunoprecipitation experiments using either anti-His antibody (to detect recombinant ISM) or anti-integrin antibody (to detect a particular integrin subunit or heterodimer) were carried out. As shown in
). On the other hand, only anti␣v␤5, anti-␣v or anti-␤5 antibodies could co-precipitate ISM. Furthermore, ISM-C interacted with ␣v␤5 but not ISM-N (Fig. 6, part G and data not shown). These results suggest that ISM could interact with ECs through ␣v␤5 integrin.
To further confirm this, anti-␣v␤5 neutralizing antibody was pre-incubated with ECs before cells were plated onto ISM-coated surface. As shown in Fig. 6 , anti-␣v␤5 antibody partially but significantly blocked EC attachment to ISM-coated surface (Fig. 6, 
part H). Under the same condition, normal mouse IgG or anti␣v␤3 antibody did not present significant blocking of EC attachment to ISM-coated surface. These results demonstrate that ISM interacts with ECs at least partly through ␣v␤5 integrin. © 2011 The Authors Journal of Cellular and Molecular Medicine © 2011 Foundation for Cellular and Molecular Medicine/Blackwell Publishing Ltd
Fig. 4 The effects of ISM and its various domains on various aspects of in vitro angiogenesis. (A) ISM does not influence VEGF-induced chemotactic EC migration. The concentrations of ISM, ISM-N, ISM-C and ISM-TSR tested were from 1 nM to 1 M. Only results of 1 M were shown. (B) ISM suppressed VEGF-induced EC proliferation. Both ISM-N and ISM-C have a weaker activity comparing to ISM, whereas ISM-TSR is not active. Only 1 M result was shown for ISM-TSR. (C) ISM induced EC apoptosis in the presence of VEGF in a dose-dependent manner. The ISM-induced EC apoptosis was abolished when pan-caspase inhibitor z-VAD-fmk was added.
None of the ISM truncated fragments (at concentrations from 10 nM to 1M) showed such activity (only 1 M result was shown) *P Ͻ 0.05, **P Ͻ 0.01, n ϭ 4. VEGF used was 15 ng/ml in all experiments. (Fig. 7 and data not shown) . [23] . VEGF is also highly expressed in xenograph B16F10 tumour in mice [25, 26] [27] . was studied by whole mount in situ hybridization. ism is expressed from the late gastrulation/early segmentation stage in the MHB and in the posterior trunk region (Fig. 9A and B) . Subsequently, its expression is restricted in the tail bud region and notochord. At 22 hrs after fertilization (hpf), high level expression was observed in the notochord, MHB (Fig. 9D) . The tail bud expression declined by 30 hpf (Fig. 9E) . Notochord expression declined at 48 hpf and disappeared by 72 hpf (Fig. 9F and G [28] . As shown in Fig. 9 , a splicing-interference MO (spl MO) dosedependently disrupted ISV formation in the trunk during the second day of embryogenesis, the period when ISV forms through angiogenesis by branching from the dorsal aorta and axial vein (Fig. 9) . In ism morphants which showed no gross trunk morphological defects, ISVs were often mis-joined (Fig. 9H, morphant 1) . In ism morphants which showed a curved body, severe ISV defects were observed, with some ISVs failed to form (Fig. 9H, morphant 2) . In contrast, the dorsal aorta and axial vein were formed normally through vasculogenesis in these morphants. Semi-quantitative RT-PCR showed that the endogenous ism mRNA was effectively reduced about 70% in the morphants (Fig. 9) 
Fig. 5 Effects of ISM and its domains on EC attachment and spreading. (A) ISM does not interfere with EC attachment to gelatin-coated surface. Neither ISM nor its truncated fragments at various concentrations have any effect on EC attachment to gelatin-coated surface. (B) ECs can attach and spread onto ISM coated surface. ISM-C support EC attachment and spreading as efficient as ISM whereas ISM-N cannot support this function.
ISM inhibits angiogenesis in vivo
To further examining if ISM could inhibit angiogenesis in vivo, we used a modified Matrigel plug angiogenesis assay in which the Matrigel is retained in a silicon tube angioreactor. In each mouse, a control and experimental angioreactor was implanted subcutaneously into each side of the dorsal flank to reduce variations between individual mice. The amount of angiogenesis in each angioreactor was quantified by measuring the number of ECs using fluorescently labelled EC-binding lectin. As shown in Fig. 7, a mixture of VEGF and bFGF induced potent angiogenesis in mice compared to control (Matrigel alone). When ISM was added together with VEGF/bFGF, it potently suppressed VEGF/bFGF induced angiogenesis at 0.5 M and 1 M, concentrations where it is also effective in inhibiting angiogenesis in vitro. These results demonstrate that ISM functions as an angiogenesis inhibitor in vivo. Surprisingly, when ISM-C was tested under the same experimental condition, it did not suppress in vivo angiogenesis at 0.5 M or 1 M
Overexpression of ISM in B16F10 melanoma cells suppressed tumour angiogenesis and tumour growth in mice
. Because ISM potently inhibits VEGFinduced angiogenesis in vitro, it is possible that ISM also suppressed VEGF induced angiogenesis in B16 tumour. Interestingly, overexpression of ISM also led to reduction of melanin production in B16F10 melanoma cells (Fig. 8B). However, it is unclear at this point if the reduction of melanin production is linked to the reduced tumour progression in mice. An earlier report has shown that melanin production is not linked to B16 melanoma cell invasiveness in vitro
Knockdown of isthmin in zebrafish embryos disrupted trunk intersegmental vessel formation
To study the role of isthmin in physiological angiogenesis, we used zebrafish embryos as a model to investigate embryonic angiogenesis. Expression of ism during zebrafish embryogenesis
Discussion
Angiogenesis inhibitors play important roles in regulating angiogenesis in physiology and pathology. Over the years, very few genes have been discovered which directly code for anti-angiogenic proteins. Although ISM was discovered as a secreted protein highly expressed in the isthmus of the brain [3], its function has remained unknown. In this work, we demonstrated for the first time that ISM is a novel endogenous angiogenesis inhibitor.
Recombinant ISM inhibits angiogenesis in vitro and in vivo
Recombinant ISM inhibited multiple aspects of angiogenesis in vitro (Table 1) . It suppressed EC capillary network formation on Matrigel in a dose-dependent manner (Fig. 2) . Addition of ISM at earlier times (0-2 hrs) after EC plating inhibits capillary formation (Fig. 3) (Fig. 7) . [29, 30] 
ISM inhibits VEGF-, bFGF-and serum-stimulated EC proliferation in a dose-dependent manner (Figs 4B and S3). It also induced EC apoptosis in the presence of VEGF (or bFGF or serum) through a caspase-dependent pathway (Figs 4C, S6 and S7). Interestingly, only the full-length ISM protein has this apoptosis-inducing activity. EC survival and apoptosis are known to play key roles in angiogenesis
. However, it has no effect on tumour cell apoptosis and only induced mild apoptosis of fibroblasts in culture (Figs 4, S3, S5-S8). The specific effect on ECs could be an advantage for therapeutic drug development.
A recent report has shown that although VEGF stimulates EC chemotaxis, it reduces EC chemokinesis [31] (Fig. 6) . Anti-␣v␤5 neutralizing antibody partially blocked EC adhesion and spreading to ISM-coated surface, further supported that ISM may interact with EC and influence angiogenesis through this integrin (Fig. 6) . Because ISM has no effect on EC attachment and spreading to matrix molecules such as fibronectin, gelatin (collagen) or diluted Matrigel whose major components are laminin and collagen IV (Figs 5A and S9) . This is consistent with the fact that integrin ␣v␤5 is not the receptor for collagen, fibronectin or laminin.
Other integrins expressed in ECs such as ␣v␤3, and various ␤1 integrins do not seem to interact with ISM. Integrin ␣v␤5 is known to be highly expressed in ECs in tumour, ECs in active angiogenesis as well as in some tumour cells [24] . It is often co-targeted with ␣v␤3 integrin by pharmacological molecules to suppress tumour angiogenesis and tumour progression [24] 
ISM inhibits tumour angiogenesis in mice
B16 melanomas that stably overexpressed ISM showed markedly reduced xenograft tumour growth along with decreased tumour vascular density (Fig. 8 and data 
